by | Aug 3, 2026 | Uncategorized
FDA posted two Class I corrections for Ivenix infusion pumps used to give chemotherapy, antibiotics and pain medicine. What patients should ask.
by | Aug 3, 2026 | Uncategorized
CMS finalized changes adding Medicare Advantage patients to hospital mortality and readmission measures, which have largely relied on fee-for-service claims.
by | Aug 3, 2026 | Uncategorized
NOAA says El Niño will strengthen through year-end with a 97% chance it persists into spring 2027. What that shifts, and what it does not.
by | Aug 3, 2026 | Uncategorized
New details from Aldon Smith’s 911 call emerge as his family donates his brain for CTE research, raising awareness of brain injuries in contact sports.
by | Aug 3, 2026 | Uncategorized
The FDA selected Dexcom as the first participant in its TEMPO pilot, which pairs relaxed premarket review with real-world evidence collection.
Recent Comments